and See” Method: Most physicians favor
this approach because it does not carry the
potential risks of steroids (this is the drug most
commonly used for hemangiomas). It is reported that
there is a 10 fold-increase in complications (56%)
in lesions actively treated compared to those
managed conservatively, of which only 5% showed
scarring or redundant skin.
50% of hemangiomas involute by age 5 years, 70%
involute by age 7 years; and 90% involute by age 9
years. It should be noted that if the hemangioma
involutes late, residual skin abnormality is more
likely (fibrofatty tissue etc.).
the “wait and see” path is selected, other
treatment options (e.g. surgery, laser) are used if
there are residual skin abnormalities or
complications develop. Meanwhile, education of the
parents and help from support groups are essential
to reduce the family’s anxiety.